Massachusetts General Hospital and Harvard Medical School
Boston, Massachusetts, United States
Dr. Dougan is an Assistant Professor of Medicine at Massachusetts General Hospital and Harvard Medical School and is the Director of the Immunotherapy Mucosal Toxicities Program at Massachusetts General Hospital. He received his MD and PhD from Harvard Medical School, completing his dissertation work in Immunology with Dr. Glenn Dranoff at the Dana-Farber Cancer Institute. Dr. Dougan’s research aims to translate findings from a detailed analysis of the immune mechanisms driving immunotherapy toxicities into novel treatment strategies both for malignancies and for inflammatory diseases of gut, including gastrointestinal immune-related adverse events. His clinical work focuses on managing mucosal toxicities from cancer immunotherapy.
Disclosure information not submitted.